Reply to “Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac® ): Knowledge and information sources”

The "Post-marketing experience" provides information on the frequency of ADRs spontaneously reported by clinicians, compared to the number of doses of vaccines distributed during a given period. [...]post-marketing data does not reflect the actual incidence of AEs, especially regarding non-serious, expected (i.e. already identified in the labelling instructions) events. [...]the report by Panico et al. provides an opportunity to emphasise the fact that HCPs involved in vaccination could be better informed on the actual safety profiles of the vaccines they are using and on the appropriate ways of assessing and managing AEFI.